What does Biotechnologies Assets S.A. do?

Biotechnologies Assets S.A. (BST.MC) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is BST.MC's market cap?

Biotechnologies Assets S.A. (BST.MC) has a market capitalization of approximately $15.1 million, as of July 22, 2026, based on the most recent share price and shares outstanding.

Does BST.MC pay a dividend?

Yes — Biotechnologies Assets S.A. (BST.MC) has a dividend payment history. The most recent payment, frequency, and full history are on the Dividend tab.

Is BST.MC profitable?

Biotechnologies Assets S.A. (BST.MC) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

BST.MC

Biotechnologies Assets S.A.

BME·Biotechnology · Healthcare

€0.20€0.00+0.00%

Market cap€15.07M·Market closed·Jul 22 8:17 AM UTC

Price Chart

€0.20+€0.00 (+0.00%)today

−59.80%CAGR −16.66%

Select date range

FromTo

Jan 26, 2012Jul 22, 2021 → Jul 22, 2026· 5.0 yrsJul 22, 2026

Key Metrics

BST.MC does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings Date—

Last Report DateDec 31

Reported vs Estimate−€0.02

Earnings Surprise—

FinancialsFinancials Tab

Revenue€6.06M

Net Income−€4.83M

Net Margin−79.8%

Operating Cash Flow−€86.96K

Capital Expenditures€15.76K

Free Cash Flow−€102.72K

Return on Equity−78.2%

Return on Invested Capital−6.1%

Net Debt€1.08M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for BST.MC and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how BST.MC's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for BST.MC and 80,000+ other tickers.

About Biotechnologies Assets S.A.

Biotechnologies Assets S.A. is dedicated to conceiving, producing, and commercializing sophisticated biotechnological assets. These innovative materials are utilized across a diverse array of sectors, including biopharmaceuticals, agriculture, cosmetics, animal health, and the broader chemical industry. The company operates globally, with its headquarters located in Cádiz, Spain, where it was established in 1954.

CEO: Manuel Lopez Nieto
Sector: Healthcare
Industry: Biotechnology
Exchange: BME
Employees: 26
Website: www.biatgroup.com

Latest News

News Tab

No recent news available.

Frequently Asked Questions About BST.MC

What does Biotechnologies Assets S.A. do?: Biotechnologies Assets S.A. (BST.MC) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is BST.MC's market cap?: Biotechnologies Assets S.A. (BST.MC) has a market capitalization of approximately $15.1 million, as of July 22, 2026, based on the most recent share price and shares outstanding.
Does BST.MC pay a dividend?: Yes — Biotechnologies Assets S.A. (BST.MC) has a dividend payment history. The most recent payment, frequency, and full history are on the Dividend tab.
Is BST.MC profitable?: Biotechnologies Assets S.A. (BST.MC) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.